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Summary
Epigenetic changes in chromatin structure at the T
helper (Th2) locus correlate with interukin-4 (IL-4)
and IL-13 expression during Th2 differentiation. By
using a transgenic green fluorescence protein (GFP)
reporter system, we show that conserved noncoding
sequence-2 (CNS-2), located downstream of the Il4 lo-
cus, is a constitutively active enhancer in NKT cells as
well as in a subset of CD44hi memory phenotype CD4+
T cells. CNS-2 enhancer activity and initial IL-4 expres-
sion inCD44hi CD4+ T cells were abolished inmicewith
a CD4-specific deletion of the transcriptional mediator
of Notch signaling, Rbp-j. Depletion of CNS-2 active
CD4+ T cells markedly decreased Th2 differentiation
from naive CD4 T cells and antigen-specific IgE pro-
duction after in vivo priming. These findings indicate
that Notch-regulated CNS-2 enhancer controls initial
IL-4 expression in NKT and memory phenotype CD4+
T cells and that CNS-2 active CD44hi memory pheno-
type T cells are important in facilitating Th2 differenti-
ation of naive CD4+ T cells in allergic responses.
*Correspondence: raysolfc@rcai.riken.jpIntroduction
Naive CD4 T cells differentiate into effector T cells of at
least two distinct subsets that can be defined based on
nonoverlapping cytokine expression patterns. T helper 1
(Th1) cells secrete IFN-gand participate mainly in cellular
immune responses against intracellular pathogens and
viruses. In contrast, T helper 2 (Th2) cells produce inter-
leukin-4 (IL-4), IL-5, and IL-13, which are involved in
humoral immune responses mainly against extracellular
pathogens. IL-4 and IL-5 are strongly implicated in
atopic and allergic disease because of their role in regu-
lating IgE-mediated immune responses via mast cells
and eosinophils. The nonoverlapping cytokine expres-
sion patterns in Th1 and Th2 cells are controlled by her-
itable states of transcriptional activation and repression
established during the differentiation process. For ex-
ample, programmed chromatin structure modifications
in the Il13-Il4 locus correlate well with the lineage-spe-
cific transcriptional competence of Th2 cytokine genes.
Chromatin modification controls accessibility of tran-
scriptional activators and repressors in discrete regions
of the locus, and these have been identified as DNase I
hypersensitive (HS) sites (Agarwal and Rao, 1998).
The genetic configuration of the Il13-Il4 locus on
mouse chromosome 11 and human chromosome 5 is
well conserved, and both genes have the same tran-
scriptional orientation. Clusters of HS sites have been
characterized at the Il13-Il4 locus on the basis of lineage
specificity and activation dependence. HSS1, HSS2,
HS0, HS-1, HS-2, HS-3, and HS-5 are Th2-specific con-
stitutive HS sites, and HS-5a is a Th2-specific and acti-
vation-dependent site (Agarwal et al., 2000; Guo et al.,
2004; Takemoto et al., 1998). HSS3 and HS-4 are consti-
tutive HS sites commonly observed in naive, Th1, and
Th2 cells (Agarwal and Rao, 1998; Takemoto et al.,
1998). Comparative crossspecies analysis of genomic
sequences reveals considerable conservation of non-
coding sequences, and the HS sites in the Il13-Il4 locus
often correlate with the conserved regions. Conserved
noncoding sequences (CNS)-1 and 2 correspond to
HSS1 and 2 and to HS-5, respectively (Agarwal and
Rao, 1998; Loots et al., 2000; Takemoto et al., 1998).
T cells from mice lacking either CNS-1 or CNS-2 have
a marked reduction in their ability to secrete Th2 cyto-
kines. However, Th2 cytokine production is not abol-
ished completely in either of the mutant mice (Mohrs
et al., 2001a; Solymar et al., 2002), suggesting that the
activity of either element alone cannot explain the line-
age-specific transcriptional competency of Th2 cyto-
kine genes. Therefore, genetic deletion experiments
are not sufficient to define the functional role of those
elements in lineage-specific gene expression.
Studies with transgenic IL-4 promoter-luciferase re-
porter constructs controlled by different genomic frag-
ments of the Il13-Il4 locus indicate that coordination
of multiple regulatory elements is necessary for line-
age-specific Th2 cytokine expression, since individual
elements (HSS1 and 2, HS-2, HS-4, or HS-5a and 5)
did not restore normal IL-4 expression. Lee et al. have
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(Lee et al., 2001), although the HS-2 region was a mast
cell-specific enhancer (Hural et al., 2000). None of the
potential regulatory elements in the Il13-Il4 locus sat-
isfies the criteria of a locus control region (LCR), be-
cause they do not confer copy number-dependent ex-
pression. Recent studies reported that a HS site at the
30 end of the Rad50 gene, RHS7, plays a role as LCR
(Lee et al., 2005). Gene disruption of RHS7 decreased,
but did not eliminate, the production of cytokines from
the Il13-Il4 locus, similar to the behavior observed in
CNS-1-deficient mice (Mohrs et al., 2001a). These re-
sults suggest that RHS7 acts as an important lineage-
specific regulator but that involvement of other elements
in the induction of full Th2 differentiation remains likely.
To gain further insight into the role of the cis-acting
activity of CNS on lineage specificity, we developed a
transgenic approach by using green fluorescence pro-
tein (GFP) as a reporter, allowing analysis at the single-
cell level, and this GFP Tg mouse indicates that the
CNS-2 enhancer is predominantly active in a subset of
memory phenotype (MP) CD4 T cells as well as in NKT
cells. The CNS-2 contains multiple putative binding sites
for RBP-J, a critical modulator for Notch signaling.
Notch is an evolutionally conserved receptor that regu-
lates cell fate decisions in various tissues (Artavanis-
Tsakonas et al., 1999). Ligand binding to Notch leads
to a series of proteolytic processing events (Maillard
et al., 2003; Schroeter et al., 1998), and the released in-
tracellular domain translocates to the nucleus and acts
as a transcriptional activator through association with a
DNA binding protein, RBP-J (Honjo, 1996). The mamma-
lian Notch family consists of four members, all of which
use RBP-J as a transcriptional mediator (Kato et al.,
1997; Maillard et al., 2003). We and other groups have re-
ported that conditional deletion of Rbp-J in CD4 T cells
selectively impairs APC-induced Th2 differentiation
(Amsen et al., 2004; Tanigaki et al., 2004). Amsen et al.
proposed that Notch signaling directly promotes an in-
structive signal for Th2 differentiation; however, most
of the impaired differentiation observed in RBP-J-defi-
cient mice was restored by the addition of IL-4. There-
fore, the role of Notch-mediated binding of RBP-J to
CNS-2 still remains unclear.
In the present study, we found that CNS-2 regulates
IL-4 production in MP cells and NKT cells. The depletion
of CNS-2-regulated T cells resulted in a reduction of Th2
cytokine production upon secondary stimulation. Our
data indicate that the loss of Th2 development in Rbp-
j-deficient mice is caused mainly by an abrogation of
the initial IL-4 production by these CNS-2-regulated
T cells. Therefore, Notch activation in MP cells and
NKT cells regulates IL-4 production through the binding
of RBP-J to the CNS-2 region of the Il4 locus. Notch- and
RBP-J-mediated initial IL-4 production may thus have
an important role in instructing naive CD4 T cells to dif-
ferentiate into Th2 cells.
Results
The CNS-2 cis-Acting Element Correlates
with Th2-Specific IL-4 Expression
We used a transgenic approach to define a role of CNS
and HS site in regulating IL-4 expression. A basicconstruct was generated by insertion of lineage nonspe-
cific enhancer (Kubo et al., 1997) into IL-4 promoter GFP
reporter construct (pIL-4 GFP). As a positive control, the
human CD2 locus control region was inserted down-
stream of pIL-4 GFP (hCD2LCR). An intronic enhancer
(IE) and proximal and distal 30 (p30 and d30) elements
were placed downstream of the basic construct. Each
element contains CNS and HS sites as shown in Fig-
ure 1A. GFP expression was analyzed at the single-cell
level by flow cytometry.
No GFP expression from pIL-4 Tg was found in un-
stimulated CD4 T cells or in developing Th1 and Th2 cells,
whereas GFP expression was clearly induced in Th1 and
Th2 cells prepared from hCD2LCR transgenic mouse
(Tg) (Figure 1B). These results indicate that the CD2
LCR is capable of driving the IL-4 promoter in a specific
fashion and validates the function of our construct for
reporting regulatory element activity in Tg. We next re-
placed hCD2LCR with IE and p30 and d30 elements and
found that IE and p30 Tg lines showed no GFP expres-
sion in T lineage cells (Figure 1B).
Th2-specific GFP expression was found only in the d30
Tg. About 5% of Th2-primed CD4 cells expressed de-
tectable levels of GFP in four independent Tg lines
(Figure 1B). Unexpectedly, GFP was constitutively ex-
pressed in an unstimulated CD4 cells from all eight indi-
vidual d30 Tg lines that were established in the present
study (Figure 1C, middle), and the proportion of GFP-ex-
pressing T cells was comparable between unstimulated
and Th2-primed cells (Figure 1C, right). The following
analysis for d30 Tg was carried out with line 1.
The d30 fragment contains the HS5a and HS5 hyper-
sensitive sites. HS5a is inducible in restimulated Th2
cells, and HS5 corresponds to CNS-2 (Agarwal et al.,
2000; Ansel et al., 2006). To narrow down the region driv-
ing GFP expression, we generated two mutant Tg lines
in which HS5a or both HS5 and 5a was deleted from
the d30 (D5a and D5 and 5a Tg). The proportion of
GFP+ cells in D5a and d30 Tg was comparable, although
low copy number lines (line 1 and 2) showed no GFP ex-
pression (Figure 1D). Further deletion of the HS5 site
abolished GFP expression in unstimulated CD4 cells
(Figure 1D). These results indicated that the CNS-2 re-
gion is responsible for GFP expression in a subset of
resting CD4 T cells and developing Th2 cells.
NKT and MP Cells Constitutively
Express GFP in d30 Tg
Next, we investigated the cell-surface phenotype of
GFP-expressing CD4 T cells from d30 Tg and D5a Tg
and found that the cells were CD4+CD44hiCD62Llo
CD252 (Figure 2A). Two strains of IL-4 GFP knockin
mice, G4 and 4get, have been reported to express
GFP in unstimulated CD4 cells (Hu-Li et al., 2001; Mohrs
et al., 2001b). Most GFP+ cells in those strains were
identified as NKT cells. Thus, GFP+ CD44hiCD4 cells in
the d30 and D5a Tg may include NKT cells. However,
only half of the GFP+ splenic CD4 cells in d30 Tg and
D5a Tg expressed NK1.1 and bound to a-galcer-loaded
CD1d-Ig (aGC-CD1d) (Figure 2B), indicating that GFP+
cells comprise both NKT cells and MP CD4 subset.
We further examined the distribution and localization
of GFP+CD4 T cells. GFP+ cells were found in the thy-
mus, and GFP was predominantly expressed in CD4
Il4 Enhancer and Notch in Th2 Differentiation
691Figure 1. GFP Expression in Freshly Isolated CD4 T Cells and Restimulated Th1 and Th2 Cells
(A) Diagram of the Il4 locus and constructs for transgenic mice. Arrows indicate HS sites, and the CNS-2 region is indicated as an open box.
Horizontal bars indicate fragments that were used for transgenic reporter constructs. All GFP reporter constructs used in this study are shown.
(B) GFP expression from unstimulated T cells and restimulated developing Th1 and Th2 cells. Unstimulated splenic T cells were freshly isolated
from each Tg line. CD4 T cells were stimulated with TCR and CD28 mAbs under Th1 or Th2 conditions. After 7 days, cells were restimulated with
TCR mAb and GFP expression was assessed. More than four independent lines were examined for each construct, and the data are represen-
tative of three experiments. Numbers in each column represent percentage.
(C) GFP expression was assessed in unstimulated (closed bar) and restimulated Th1 (open bar) and Th2 (closed bar) spleen CD4 T cells from p30
(5 lines) and d30 (8 lines) Tg mice. The data indicate the proportion of GFP+ cells in each Tg line. The copy number of each line is shown in the lower
column. Data indicate mean 6 SD; n = 3 for lines 1, 2, and 4 of unstimulated Tg and lines 1 and 2 of restimulated Tg.
(D) GFP expression was analyzed in freshly isolated spleen T cells fromD5a+5 andD5a Tg mice in each 5 line. The proportion of GFP+ CD4 T cells
is indicated. Data indicate mean 6 SD; n = 10 and 14 for lines 4 and 5 of D5a Tg, respectively.single-positive (SP) but not double-positive (DP) or CD8
SP thymocytes (Figure 2C). CD4 T cells prepared from
lymph node (LN) and peripheral blood (PB) also showeda correlation between GFP and CD44 expression, al-
though their proportion was much smaller than those
from the spleen and thymus (Figure 2D). Therefore,
Immunity
692Figure 2. Cell-Surface Phenotype and Distribution of GFP+CD4+ T Cells
(A) CD4 and CD8 expression were analyzed on splenic T cells of d30 Tg mice, and CD44, CD62L and CD25 were analyzed on the CD4 T cells.
(B) Splenic CD4 T cells from d30 Tg mice backcrossed with C57BL/6J were stained for NK1.1 and aGC-CD1d (left top), and GFP expression was
analyzed in gated NK1.12, Gal-CD12 from normal (wt; shaded area) and d30 Tg (Tg; unshaded area) (right). GFP expression was further examined
in NKT and NK1.12, Gal-CD1 T cells (left bottom). The number indicates a percentage of GFP+ cells.
(C) GFP expression was analyzed in CD8 SP, CD4 SP, and DP of d30 Tg thymocytes.
(D) Distribution of GFP+ cells in LN and PB. The data are representative of three independent experiments.CNS enhancer was active in both NKT cells and MP CD4
subset, and this T cell subset not only localized in
spleen, but also localized in thymus, LN, and PB.
CNS-2 Is Not Active in Developing Th2 Cells
Derived from Naive CD4 T Cells
Typically, when CD4 T cells are cultured in Th2 priming
conditions, 30% to 40% of cells produce IL-4 upon re-
stimulation with anti-TCR. However, in d30 Tg, the popu-
lation of GFP+ cells was only about 10% of CD4 T cells.
Without stimulation, GFP was expressed only in CD44hi
cells. It is possible therefore that those GFP+ cells de-
rived from naive CD4 T cells that became GFP+ after
Th2 commitment. We examined whether unstimulated
GFP+ (MP+NKT) or GFP2 (naive) cells are capable of be-
coming GFP+ Th2 cells. Sorted unstimulated GFP+ and
GFP2 CD4 cells were each cultured in Th1- and Th2-
priming conditions for 1 week. After restimulation, GFP
expression and cytokine production were analyzed.
GFP expression was observed predominantly in de-
veloping Th2 cells derived from the NKT and MP pop-
ulations when GFP was expressed in unstimulatedsituation (Figure 3A). In contrast, GFP2CD4 T cells failed
to express GFP even though about 50% of cells secreted
IL-4 upon restimulation (Figure 3A, left). These results in-
dicated that CNS-2 is not active in effector Th1 and Th2
cells derived from naive T cells. Moreover, CNS-2 activ-
ity in GFP+ MP cells is sustained only with Th2 priming
conditions, although GFP+ cells are able to show both
Th1 and Th2 phenotype (Figure 3A). On the other hand,
purified NKT population did not become Th1 and Th2
cells by induction culture (data not shown). These re-
sults indicate that CNS-2 can regulate IL-4 promoter
activity in MP cells both in initial and secondary stimula-
tion. However, IL-4 expression in conventional Th2 cells
differentiated from naive T cells may be regulated by
a CNS-2-independent mechanism. Therefore, it is likely
that GFP+ MP cells in d30 Tg are not effector Th2-derived
memory cells.
We further asked whether CNS-2 activity was sus-
tained in MP CD4 T cells during Th2 differentiation.
When unstimulated GFP+ CD4 cells from d30 Tg were
activated, GFP expression gradually decreased and
then disappeared within 6 days with both Th1 and Th2
Il4 Enhancer and Notch in Th2 Differentiation
693Figure 3. CNS-2 Regulates Enhancer Activity in Developing Th2 Cells Derived from Unstimulated GFP+CD4 T Cells
(A) 13 106 of GFP+ and GFP2 CD4 cells were sorted from d30 Tg and stimulated with TCR and CD28 mAbs in either Th1 or Th2 condition. After 6
days, cells were restimulated with TCR mAb, and IFN-g and IL-4 production and GFP expression were analyzed. Left panel shows the efficiency
of Th1 and Th2 differentiation derived from the GFP2 CD4 cells. GFP expression (middle) and IL-4 and IFN-g production (right) were analyzed in
the precultured GFP+ and GFP2 cells under Th1 (open bar) and Th2 (closed bar) conditions.
(B) CD4 cells from d30 Tg were cultured for 1 to 6 days in either Th1- (open circle) or Th2- (closed square) skewed conditions. Cells were restimu-
lated with TCR mAb at the time points indicated with arrows. Data are mean 6 SD from six experiments.priming. However, upon restimulation, GFP expression
reappeared in Th2- but not Th1-primed cells (Figure 3B).
Therefore, CNS-2 activity is downregulated with initial
TCR activation and restored with Th2 priming. Th2-spe-
cific CNS-2 activity only reappeared upon restimulation.
CNS-2 Enhancer Activity in GFP+ NKT and MP Cells
Plays a Role as the Initial IL-4 Source during Th2
Differentiation
Next we asked how CNS-2 activity relates to the ability
to secrete IL-4 upon initial activation. CD4 T cells from
d30 Tg were separated by sorting into three fractions
based on CD44 and GFP expression, and cytokine pro-
duction was assessed in initial T cell activation. CD44lo
naive CD4 T cells produced high levels of IL-2 but not
IL-4 and IFN-g, CD44hiGFP2 cells expressed IL-2 and
IFN-g but not IL-4, but CD44hiGFP+ cells secreted high
levels of IL-4 (Figure 4A), comparable to levels of IL-4
produced by effector Th2 cells. Intriguingly, the GFP+
cells simultaneously secreted not only Th2 cytokines,such as IL-5, IL-10, and IL-13, but also several Th1 cyto-
kines (IL-2 and IFN-g) (Figure 4A).
Since GFP+ cells include both NKT and MP cells, we
next asked whether both populations are comparable
in their ability to secrete IL-4. Thus, we analyzed IL-4
production in NKT-depleted GFP+ cells and found that
GFP+ MP cells have the capability to secrete a compara-
ble amount of IL-4 to that of NKT cells (Figure 4B), indi-
cating that both NKT and MP cells are capable of pro-
ducing IL-4 after initial activation. Therefore, CNS-2 is
likely a critical regulatory element for primary IL-4 pro-
duction by both NKT and MP CD4 cells.
We next asked whether GFP+ NKT and MP cells might
be the initial IL-4 source for conventional Th2 priming. If
this is the case, then Th2 cytokine production in second-
ary responses should be decreased by depletion of
GFP+ T cells. In order to test this hypothesis, GFP+ cells
were depleted from the total CD4 T cell population and
stimulated with TCR mAb. As shown in Figure 4C, the
depletion of the GFP+ cells abrogated all Th2 cytokine
Immunity
694Figure 4. Cytokine Production by GFP+ T
Cells during Primary Activation
(A) Freshly isolated CD4 T cells from d30 Tg
were divided into three populations: CD44lo
GFP2 (open bar), CD44hiGFP2 (gray bar),
and CD44hiGFP+ cells (closed bar). ‘‘G’’ indi-
cates GFP+. Three sorted populations were
stimulated with TCR and CD28 mAbs for
48 hr and cytokine production was measured.
Data indicate mean 6 SD of three experi-
ments.
(B) aGC-CD1d+ cells were deleted from GFP+
BALB/c CD4 T cells (5 3 105/ml). Purity of
NKT-deleted cells (DNKT) was indicated at
upper panel. Whole CD4 T cells (open bar)
and NKT-depleted population (closed bar)
were stimulated with TCR and CD28 mAbs
for 48 hr. IL-4 and IFN-g production was mea-
sured by ELISA. Data for IL-4 production indi-
cate mean 6 SD of three experiments.
(C) GFP+ cell depletion impaired Th2 cytokine
production in secondary responses. GFP+
cells were depleted from whole splenic CD4
T cells of d30Tg. Whole (open bar) and GFP2
CD4 (closed bar) cells were stimulated with
TCR and CD28 mAbs under nonpolarizing
condition. GFP2 cells were cultured in the ab-
sence (2) (closed bar) or presence (IL-4) (gray
bar) of exogenous IL-4 (100 U/ml). After 1
week, cells were restimulated and assessed
cytokine production by ELISA.production, including IL-4, IL-5, IL-13, and IL-10. This
impairment was completely restored by the addition of
exogenous IL-4. Therefore, these results demonstrate
that GFP+CD4 T cells can act as an essential initial IL-4
source determining Th2 differentiation.
Constitutive Expression of IL-4 mRNA in GFP+NKT
and MP Cells
In order to explore the functional significance of consti-
tutive CNS-2 activity, we further examined IL-4 mRNA
expression in GFP+CD4 cells with or without TCR activa-
tion. Constitutive expression of IL-4 mRNA was found by
RT-PCR with three different primer combinations in un-
stimulated GFP+ cells (Figure 5A, left). IL-4 mRNA levels
increased 30-fold when cells were stimulated (Figure 5A,
right). This TCR-mediated IL-4 mRNA induction was
found only in GFP+ cells but not in naive and GFP2 MP
cells, while IFN-g mRNA induction was detected in
both GFP+ and GFP2 CD44hi MP cells (Figure 5A, right).
Therefore, CNS-2 may contribute to basal levels of IL-4
mRNA in NKT and MP cells, both of which have the po-
tential to secrete high levels of IL-4.CNS-2 Enhancer Activity in NKT and MP Cells Is
Independent of STAT6 Signaling
GATA-3 is known to be a master regulator of Th2 differ-
entiation; its expression is tightly regulated by IL-4-
STAT6 signaling (Kurata et al., 1999; Zheng and Flavell,
1997; Zhu et al., 2004). Thus, we tested the requirement
of STAT6 for initial IL-4 production in NKT and MP cells.
CNS-2-regulated GFP expression in d30 Tg mice was not
affected in unstimulated T cells from STAT6-deficient
(KO) mice (Figure 5B). In this circumstance, initial IL-4
production was also found (data not shown).
The presence of IL-4-producing cells has been re-
ported in STAT6 KO mice, and these cells constitutively
express high levels of GATA-3 (Ouyang et al., 2000).
Therefore, GFP expression in NKT and MP cells is likely
due to constitutive expression of GATA-3. To test this,
we isolated GFP+ and GFP2 cells from 30 Tg mice and
measured GATA3 protein expression. Detectable levels
of GATA-3 protein expression were not observed in ei-
ther GFP+ or naive CD4 T cells (Figure 5C). GFP activity
observed with Th2 development was completely abol-
ished in STAT6 KO mice (Figure 5B). Thus, STAT6 and
Il4 Enhancer and Notch in Th2 Differentiation
695Figure 5. Constitutive Expression of IL-4
Transcripts in GFP+ Cells
(A) Top panel: Schematic of the Il4 locus
illustrating primer (/) and probe (2) design
for the measuring IL-4 mRNA expression.
Bottom left: Quantitative RT-PCR was carried
out with different primer sets. Three CD4+
populations, CD44lo GFP2 (open bar),
CD44hiGFP2 (gray bar), and CD44hiGFP+
(closed bar) cells, were sorted from CD4 T
cells from d30 Tg, and IL-4 mRNA was mea-
sured by TaqMan PCR. Minus sign and ‘‘G’’
indicate GFP2 and GFP+ cells, respectively.
Bottom right: Three sorted populations were
stimulated for 48 hr, and TaqMan RT-PCR
was carried out with ex1-4 primer set. Plus
and minus signs indicate presence (closed
bar) and absence (open bar) of TCR stimula-
tion, respectively.
(B) CNS-2-mediated constitutive GFP ex-
pression is independent of STAT6. GFP ex-
pression was analyzed in freshly isolated
CD4 cells and developing Th2 cells from d30
Tg mice on a wt or STAT6-deficient (KO)
background.
(C) GATA-3 protein expression was detected
by Western blotting with GATA3 mAb in cell
extracts from freshly isolated naive and
GFP+ CD4 cells of d30 Tg mice. Resting
cloned Th1 and Th2 cells were used as con-
trol for GATA3 expression. STAT6 is an inter-
nal control.GATA-3 expression may not be essential for CNS-2 ac-
tivity in NKT and MP CD4 T cells.
CNS-2 Enhancer Activity in NKT and MP Cells Is
Regulated by Notch and RBP-J Signaling
Three possible binding sites for RBP-J have been iden-
tified in CNS-2 region (Amsen et al., 2004). Therefore, to
identify the transcription factors that regulate CNS-2 ac-
tivity in NKT and MP cells, RBP-J seemed like a good
candidate. We have previously reported that T cell-spe-
cific conditional Rbp-j-deficient mice display impaired
Th2 differentiation and antigen-induced IgE production
(Tanigaki et al., 2004). We first examined a role of Notch
and RBP-J pathway in Th1 and Th2 differentiation
with control (+/+, CD4-cre Tg), heterozygous (f/+, CD4-
cre Tg), and Rbp-j KO (f/f, CD4-cre Tg) mice. CD4 T cells
from Rbp-j KO mice showed reduced Th2 cells (15%
to 3.5%) and increased Th1 cells (0% to 7%) that
were strictly dependent on RBP-J expression levels
(Figure 6A).
Next, we investigated a role of RBP-J binding in the in-
duction of CNS-2 enhancer activity. The d30 Tg mice
were crossed with control, heterozygous, and Rbp-j
KO mice and GFP expression was assessed. The d30
Tg mice exhibit GFP expression in CD4 T cells while
GFP+ cells were totally absent in the Rbp-j-deficient
T cells (Figure 6B). These results demonstrate that the
Notch and RBP-J signaling pathway regulates CNS-2
enhancer activity in NKT and MP cells.
We further tested whether impaired Th2 differentiation
is due to a loss of initial IL-4 production from CNS-2active CD4 T cells. CD44hi and CD44lo T cells were iso-
lated from wild-type, heterozygous, and Rbp-j KO mice
and stimulated with TCR and CD28 mAbs in the presence
of CD11c+ DCs. Upon initial T cell activation, IL-4 and
IFN-g were secreted from CD44hi but not CD44lo CD4
cells of wild-type mice. IL-4 production was markedly
decreased in heterozygous mice, and CD44hi CD4 cells
from the conditional Rbp-j KO mice failed to produce
IL-4 (Figure 6C, left). CD44hi CD4 cells secrete relatively
high amount of IFN-g, and IFN-g production was also re-
duced in a dose-dependent manner. However, the re-
duction in IFN-g levels of Rbp-j KO mice was only about
a half to a third of that of control mice (Figure 6C, right).
Therefore, Notch and RBP-J signaling is likely to be
more critical for initial IL-4 production in NKT and MP
cells.
Next, we asked how Notch-dependent IL-4 produc-
tion in CD44hi cells impacts Th2 differentiation. To an-
swer this question, CD44lo naive T cells from wild-type
mice were cocultured with CD44hi CD4 T cells from
either wild-type or Rbp-j KO mice. Coculture with wild-
type CD44hi cells showed clear Th2 differentiation, but
no Th2 cells were generated in the Rbp-j-deficient
cocultures (Figure 6D). In contrast, Th1 differentiation
was comparable in cocultures of CD44lo naive and
CD44hi T cells from RBP-J KO and control mice
(Figure 6D). These results demonstrate that Notch and
RBP-J signaling is essential for Th2 but not Th1 differen-
tiation and that it plays an important role in the initial in-
duction of IL-4 from CD44hi NKT and MP cells. This im-
pairment of Th2 differentiation in Rbp-j-deficient
Immunity
696Figure 6. Notch and RBP-J Signaling Regulates CNS-2-Mediated Initial IL-4 Production in CD44hi CD4 T Cells
(A) Splenic CD4 T cells were isolated from CD4cre3Rbp-j +/+ (+/+), CD4cre3Rbp-j f/+ (f/+), and CD4cre3Rbp-j f/f (f/f) mice and cells were stim-
ulated with soluble TCR and CD28 mAb in the presence of irradiated DCs. After 1 week, cells were restimulated with TCR mAb to analyze IL-4-
and IFN-g-producing cells.
(B) The d30 Tg were established in the background of +/+, f/+, and f/f mice, and GFP expression in CD4 T cells was assessed after TCR stimu-
lation.
(C) CD44lo and CD44hi cells were sorted from +/+, f/+, and f/f and stimulated with soluble TCR and CD28 mAb in the presence of irradiated DCs or
immobilized TCR and CD28 mAb. After 24 hr, IL-4 and IFN-g production were assessed by ELISA. Data represent mean 6 SD of three experi-
ments. The data for IFN-g production showed soluble TCR and CD28 mAb stimulation.
(D) CD44lo and CD44hi CD4 cells were sorted from +/+ and f/f mice and cocultured in four different combinations. CD44lo and CD44hi cells were
mixed at a 5:1 ratio. Cells were activated as described in (A) and, after 1 week, ICS was carried out.T cells is likely due to the loss of initial IL-4 production by
CNS-2 active CD4 T cells.
CNS-2ActiveMPCells Are Essential for the Induction
of Th2 Responses after Ex Vivo and In Vivo Priming
Finally, we examined the role of RBP-J in regulating
CNS-2 active CD4 T cells for initiation of Th2-mediated
responses. In these experiments, OVA-induced Th2 dif-
ferentiation was assessed in the presence or absence
of CNS-2 active NKT and MP cells. CD4 T cells from
d30XDO11.10 double Tg mice contained detectable num-
bers of GFP+ cells among the TCR transgene-derived
KJ-1+ T cells (Figure 7A, left top) but had no CD1d binding
NKT cells (data not shown). When CD4 T cells from these
micewere stimulated with ovalbumin (OVA)peptide in the
context of splenic DC, depletion of the GFP+ cells re-
sulted in a complete loss of Th2 differentiation (Figure 7A,
right). Few IL-4-producing cells express GFP (Figure 7A,
left bottom), indicating that more IL-4-producing cells
were differentiated from naive T cells. These results
suggested that MP cells play an important role in the
induction of Th2 differentiation in an antigen-specific
response.
We further investigated the importance of CNS-2
active NKT and MP CD4 T cells in the induction of Th2-
mediated responses in vivo. BALB/c rag KO mice werereconstituted with d30 Tg-derived CD4 T cells and B cells
and then immunized with OVA in alum. Depletion of the
GFP+ cells resulted in a dramatic reduction in OVA-spe-
cific IgE production (Figure 7B). Consistent results were
also observed with in vivo OVA-pulsed splenic DCs
(Figure 7C). Reconstitution with NKT- and MP-depleted
CD4 T cells from d30 Tg caused significant reduction of
total IgE and slight decrease in IgG1. These mice
showed no OVA-specific IgE, while clear specific IgE
was produced with NKT-depleted CD4 T cells. However,
depletion of NKT cells alone caused a slight decrease in
IgG2a production but did not affect IgG1 or IgE (Fig-
ure 7C). Therefore, initial IL-4 production from CNS-2
active MP cells is critical for initiation of Th2-mediated
immune responses both ex vivo and in vivo.
We also asked whether CNS-2 active CD4 cells mi-
grate into inflammatory sites in response to immuniza-
tion with OVA. To test this, we assessed infiltration of
GFP+CD4 cells from d30Tg mice into bronchiolar alveolar
lavage (BAL) fluid after inhalation of either PBS or OVA in
OVA-immunized mice. As shown in Figure 7D, signifi-
cant numbers of GFP+CD4 T cells migrated into BAL
fluid as well as into regional lymph nodes only when
mice were first primed with OVA. These results indicate
that CNS-2 active CD4 T cells have the potential to infil-
trate inflammatory sites in vivo and may contribute to
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sponse.
Discussion
In the present study, we demonstrated that the CNS-2
enhancer is responsible for the regulation of initial IL-4
production in CD62LloCD44hiCD4+ T cells. The CNS-2
active CD44hiCD4+ population contains MP and NKT
cell subsets, and both cell populations have the ability
to secrete relatively large amounts of IL-4 during initial
activation. This ‘‘primary’’ IL-4 is critical for the induction
of Th2 cells in secondary responses. Further, the IL-4-
producing MP CD4+ subset plays an important role in
the initiation of antigen-induced Th2 responses. During
initial T cell activation, Notch signaling is indispensable
for IL-4 production from CD44hiCD4 cells. Therefore,
we propose that the key function of the Notch and
RBP-J signaling pathway and the CNS-2 enhancer is
the regulation of primary IL-4 production in MP and
NKT cells.
Previous studies with a transgenic reporter approach
have demonstrated that none of the known regulatory
elements, HSS1+2, HS-2, HS-4, or HS-5a+CNS-2 (HS-
5), alone is insufficient to induce Th2-specific IL-4 pro-
moter activity and that coordination of all elements is
necessary for conventional Th2 differentiation (Lee
et al., 2001). The results obtained with our transgenic
system are consistent with these observations. Alone,
neither HS-2, HS-4, nor HS-5a+CNS-2 promotes Th2-
specific IL-4 promoter activity during the development
of naive T cells into Th2 cells. Gene disruption of
HS5a+CNS-2 abolished IL-4 expression in mast cells
and impaired conventional Th2 differentiation (Solymar
et al., 2002), indicating that these two elements are pos-
sible enhancers for IL-4 expression in mast cells and
CD4 T cells. However, our GFP Tg system clearly dem-
onstrated that CNS-2 plays a role as a lineage-specific
enhancer for IL-4 expression in MP and NKT cells.
In the present study, we provide evidence that initial
IL-4 production from MP and NKT cells dictates the gen-
eration of Th2 cells derived from naive CD4 T cells. The
MP CD4 subset was originally defined by Sprent et al.
(Tough et al., 2000), and 20% to 30% of MP CD4 T cell
in the periphery exhibit a memory-like preactivated sur-
face phenotype even in nonimmunized SPF mice. Our
d30 GFP Tg mice allow further division of MP CD4 T cells
into two subsets on the basis of CNS-2 enhancer activ-
ity. Only the CNS-2 active-MP subset secretes relatively
high amounts of IL-4 upon initial T cell activation. In d30
Tg, naive T cells fail to become GFP+ cells even in Th2
skewing condition, conventional effector Th2 cells did
not express GFP even after in vivo adoptive transfer,
and conventional memory T cells derived with homeo-
static expansion fail to show GFP expression (Figure 3,
Figure S1 in the Supplemental Data available with this
article online). These result suggested that IL-4-produc-
ing MP cells may not be memory cells derived from con-
ventional effector Th2 cells. MP cells are a unique CD4
subset responsible for innate IL-4 production in primary
antigen stimulation.
We and others have proposed that naive T cells are
a possible source of IL-4 (Bix and Locksley, 1998; Yagi
et al., 2002), but highly purified naive CD4 T cells donot secrete detectable levels of IL-4 (Figures 4A and
6C). NKT and MP cells are thought to be possible alter-
nate sources of IL-4; however, a role for NKT is contro-
versial since a-galcer-activated NKT cells predomi-
nantly promote Th1 responses (Cui et al., 1999;
Nakayama et al., 2001), while NKT cells are also essen-
tial for antigen-induced Th2-mediated airway and IgE re-
sponse (Akbari et al., 2003; Lisbonne et al., 2003; Yoshi-
moto et al., 2003; Yoshimoto and Paul, 1994). On the
other hand, the CNS-2 active MP subset develops
even in OVA-specific TCR Tg mice, and the deletion of
this subset impaired antigen-induced Th2 development.
These results suggest that MP CD4 cells might be a piv-
otal IL-4 source for antigen-induced Th2 differentiation.
The Notch and RBP-J pathway regulates initial IL-4
production in NKT and MP CD4 cells that is mainly con-
trolled by the CNS-2 enhancer. However, GATA-3 is
known to be an essential transcriptional factor in the
process to acquire the ability to produce IL-4 in second-
ary antigen stimulation, and initial induction of GATA-3
expression in naive CD4 T cells is further induced by
the IL-4 and STAT6 pathway (Kurata et al., 1999; Zhu
et al., 2004). Amsen et al. suggest that the Notch and
RBP-J pathway promotes GATA-3 expression because
overexpression of an active form of Notch1 in the preac-
tivation process induced GATA-3 and IL-4 at a similar
timing (Amsen et al., 2004). However, the CNS-2 en-
hancer in NKT and MP cells is constitutively active
even in the absence of STAT6, and initial IL-4 expression
is completely abolished in Rbp-j-deficient T cells (Fig-
ures 5 and 6). These results indicate that initial IL-4 pro-
duction is mainly regulated by the Notch and RBP-J
pathway rather than the STAT6-dependent pathway.
The role of CNS-2 during Th2 differentiation is consis-
tent with our previous observations in Rbp-j KO mice
(Tanigaki et al., 2004). The 30 enhancer has four putative
binding sites for RBP-J, and two of those are located in
the CNS-2 region. These two RBP-J binding sites are
phylogenetically conserved among many vertebrates.
The luciferase reporter experiment with a construct con-
taining both HS5a and CNS-2 showed clear enhancer
activity when Notch1 was introduced into CD4 T cells,
which suggests that RBP-J binding to CNS-2 via Notch
activation regulates Th2 commitment in an IL-4-inde-
pendent cascade (Amsen et al., 2004). However, the im-
pairment of Th2 differentiation in Rbp-j-deficient T cells
is restored, albeit incompletely, by the addition of exog-
enous IL-4 (Tanigaki et al., 2004). The activity of the d30
enhancer seems to be undetectable during the conven-
tional Th2 differentiation. The Th2 defect in the absence
of Rbp-j was more prominent in unskewed induction
conditions, suggesting that the impairment of Th2 de-
velopment in Rbp-j-deficient T cells is due to a defect
in CNS-2-mediated IL-4 production by CD44hi CD4 T
cells during initial T cell activation.
Notch and TCR signaling synergistically regulate T cell
activation after primary antigenic stimulation (Eagar
et al., 2004; Palaga et al., 2003). Previous studies indi-
cate that interaction of Delta1 with Notch3 actively pro-
motes Th1 differentiation (Maekawa et al., 2003). How-
ever, highly purified naive T cells cannot differentiate
into either Th1 or Th2 cells without cytokine addition
upon TCR stimulation (Yamada et al., 2006; Yamane
et al., 2005). Therefore, the importance of Notch3 in
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(A) CNS-2 active MP cells are crucial for Th2 differentiation in OVA-specific TCR Tg. Top left: GFP expression was assessed in KJ-1+ T cells from
DO11.103d30 double Tg mice. Right panel: Whole CD4 T cells and GFP-depleted CD4 T cells from DO11.103d30 double Tg spleen were stim-
ulated with cognate peptide (Loh15) in the presence of irradiated splenic DCs. After 1 week, cells were restimulated with anti-TCR, and IL-4- and
IFN-g-producing cells were analyzed by ICS. Bottom left: IL-4 production and GFP expression in the precultured whole CD4 T cells (3 mM of
Loh15 right panel).
(B) Whole (shaded bar) and GFP2CD4 (closed bar) cells from d30 Tg in BALB/c background (whole CD4 andDGFP) were transferred into BALB/c
Rag KO mice along with T- and DC-depleted cells. The transferred Rag KO mice were immunized and boosted with OVA. At day 3 after the final
boosting, OVA-specific IgE in sera was measure by ELISA. Data for whole CD4 represented mean 6 SD of three mice. Data of Ex 1 and 2 rep-
resented two individual mice.
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cells. Indeed, IFN-g production was reduced in MP cells
from Rbp-j-deficient mice during primary stimulation.
However, these MP cells promote comparable Th1 de-
velopment to MP CD4 T cells from wild-type mice (Fig-
ure 6). A pharmacological inhibitor for Notch cleavage,
g-secretase, selectively inhibits Th1 polarization by pre-
venting induction of t-bet expression (Minter et al.,
2005). However, CD4 T cells from Rbp-j-deficient mice
showed increased Th1 polarization compared to wild-
type littermates because Rbp-j-deficient strains caused
a selective impairment in Th2 differentiation (Figure 6A).
Moreover, Rbp-j-deficient T cells differentiate normally
into Th1 cells with the addition of IL-12 (data not shown).
In this case, the results of pharmacological inhibitors
and genetic ablation of Rbp-j led to conflicting results;
therefore, novel approaches will be required to clarify
the involvement of Notch signaling in Th1 differentiation.
Unexpectedly, MP CD4 cells differentiate into either
Th1 or Th2 cells in appropriate cytokine environments,
while the polarization was not observed in NKT cells
(Figure 3, data not shown). Similar flexibility in function
has been reported for human effector and central mem-
ory T cells (Messi et al., 2003). Since STAT6 and GATA-3
are critical for this flexibility, primary and secondary IL-4
production in CD44hi CD4 T cells are controlled by CNS-
2 in distinct mechanisms. Notch and RBP-J is a major
pathway for initial IL-4 expression, while STAT6 activa-
tion is pivotal for secondary expression.
Our data demonstrate that each cis-acting regulatory
element has distinct roles with respect to different T cell
subsets. A more detailed understanding of the func-
tional relevance of these regulatory elements at the sin-
gle-cell level may provide new mechanistic insights into
cell fate decisions during T cell development and, even-
tually, may offer novel strategies to counteract allergic
immune diseases.
Experimental Procedures
Constructs and Animals
The basic pIL-4 construct (pIL-4) was made by insertion of the 50 lin-
eage nonspecific enhancer (2863 to 25448) (Kubo et al., 1997) and
the IL-4 promoter from 264 to 2827 downstream of a GFP cDNA.
The IL-2 promoter in the IL-2P/GFP/hCD2LCR reporter construct
(Saparov et al., 1999) was replaced with the pIL-4 to generate
hCD2LCR. IE (+311 to +3534) and proximal 30 (+6231 to +10678)
and distal 30 (+11308 to +15635) fragments were isolated from
a mouse YAC clone (Research Genetics) by high-fidelity PCR. Dele-
tion mutants pBS-D (5a+CNS-2) and pBS-D5a were generated by
deleting the first 1657 bp and 244 bp, respectively, from the distal
30 fragment.
Each construct was excised with Sal I and Sac II to establish GFP
reporter transgenic mice. Each line was backcrossed onto the
BALB/c strain more than six generations. Genomic PCR screening
was carried out with GFP primers: sense, 50-gacgtaaacggcca
caagtt-30; antisense, 50-ggggtgttctgctggtagtg-30. Copy numberwas determined by Southern blotting with an IL-4 promoter probe.
The d30 Tg was further crossed with STAT6 KO and DO11.10 Tg
mice on a BALB/c background. Rbp-j f/f mice were crossed with
CD4Cre Tg mice (Makar et al., 2003). All mice used in this study
were maintained under SPF conditions. Animal care was conducted
in accordance with guidelines of RIKEN Yokohama Institute.
Cytokines and Antibodies
The reagents for ELISA and intracellular cytokine staining (ICS), anti-
IFN-g (R4-6A2 and XMG1.2 biotin), anti-IL-4 (BVD4-1D11 and BVD6-
24G2 biotin), anti-IL-2 (JES6-1A12 and JES6-5H4 biotin), anti-IL-5
(TRFK5 and TRFK4 biotin), anti-IFN-g (XMG1.2) FITC, and anti-IL-4
(11B11) PE, were purchased from BD (San Diego, CA). Mouse IL-
10 and IL-13 ELISA were purchased from BD and R&D Systems
(Minneapolis, MN), respectively. Mouse recombinant IL-4 and IL-
12 were purchased from PeproTech (London, UK). The procedures
for intracellular cytostaining (ICS) and cytokine ELISA assay have
been described previously (Yagi et al., 2002). For analysis of cell-sur-
face phenotype, the following mAb were used: CD4 (L3T4), CD8a
(53-6.7), CD44 (IM7), CD62L (MEL-14), CD25 (PC61), NK1.1
(PK136), and CD1d Ig (DimerXI) (BD PharMingen). CD1d-Ig was
loaded with a-galcer for analysis of NKT cells. The antibodies for
Western blotting, STAT6 mAb (clone38) and GATA-3 mAb (HG3-
35), were purchased from Alexis (San Diego, CA) and Santa Cruz
Biotechnology (Santa Cruz, CA), respectively.
Single-Cell Analysis of GFP Expression and Preparation of
Helper T Cells
CD4 T cells were isolated from spleen cells by means of the IMag
magnetic bead system (BD). GFP expression and cell sorting were
performed with CellQuest software and FACS Vantage (BD). Splenic
CD4 T cells (1 3 106cells/ml) were stimulated with plate bound anti-
TCRb (H57-597, 30 mg/ml) and soluble CD28 mAbs for 48 hr and cul-
tured in 30 U/ml IL-2 containing medium for 1 week. For Th1 and Th2
polarization, cells were cultured in the presence of mIL-4 (100 U/ml)/
anti-IL-12 (C15.6 and C17.8) and mIL-12 (5 ng/ml)/anti-IL-4 (11B11),
respectively. For induction of Th cells in the presence of DCs, splenic
CD4 T cells (13 106cells/ml) were stimulated under unpolarized con-
ditions by OVA peptide or soluble TCR (10 mg/ml)/CD28 mAbs in the
presence of irradiated CD11c+ DC (1 3 105cells/ml). After 1 week,
polarization profiles were analyzed after immobilized TCR mAb
stimulation.
Quantitative RT-PCR
Total RNA was isolated with TRIzol (Invitrogen, Carlsbad, CA). Quan-
titative real-time PCR was performed on a 7500 real-time PCR sys-
tem (Applied Biosystems, Foster City, CA). The primers for exon
2 and 3 (ex 2-3) were sense 50-tgcacggagatggatgtg-30, antisense
50-gccctacagacgagctcact-30, and for exon 1 and 4 (ex 1-4), sense
50-agatcatcggcattttgaacg-30, antisense 50-tgatgtggacttggactcattc-
30. A common probe FAM-50-acagcaacgaagaacaccacagag-Tamra
was also used for quantitative assay for IL-4 mRNA. The primers
and probe for exon1 and 2 (ex 1-2) have been previously described
(Grogan et al., 2001). The primer combination for exon 3 and 4 (ex 3-
4) was sense 50-gactctttcgggcttttcg-30 and an antisense primer
identical to antisense ex1-4.
Adoptive Transfer and In Vivo Priming
Whole and GFP-depleted CD4 T cells were obtained from spleen
of d30 Tg mice by FACS sorting. Splenic B cells were isolated by de-
pletion of T and dendritic cells (2.5 3 107 cells) by IMag (BD) and
were injected intravenously into Rag2 KO mice. Splenic CD11c+DCs
were enriched by the MACS system (Milteny Biotec, Germany) and
were pulsed with 10 mg/ml OVA for 16 hr. For immunization with(C) BALB/c Rag KO mice were reconstituted with whole (n = 4) (shaded bar), aGC-CD1d binding cells depleted (DNKT, n = 5) (open bar), or
DGFP(DNKT+MP, n = 3) (closed bar) CD4 T cells from d30 Tg or without CD4 T cell (n = 3) (gray bar) in the presence of B cells. The mice were
immunized with OVA-pulsed DC into foot pad and were boosted with OVA four times in 5 day interval. At week 3 and week 4, serum IgG1,
IgG2a, and IgE were measured by ELISA (left). Data indicate mean and SD. *p < 0.05 and **p < 0.01. Specific IgE for OVA were measured at
week 4 (right). Data of Ex represented individual mice.
(D) Normal and d30 Tg mice were sensitized with alum+OVA on days 1 and 14. On days 26–28, mice received aerosol challenge containing either
PBS (2) or 1% OVA (OVA). On day 30, cells were collected from BAL fluid and GFP+ CD4 cells were analyzed. The left and right panels show the
FACS profile and the relative cell numbers that migrated into BAL fluid with or without sensitization with OVA. Data indicate mean 6 SD from
three mice. **p < 0.01.
Immunity
700alum-conjugated OVA, the mixture of B cells (5 3 107 cells) and
whole or GFP-deleted CD4 T cells (8 3 106 cells), or whole spleno-
cytes (5 3 107 cells) was intravenously transferred into RAG-defi-
cient mice. Mice were sensitized by intraperitoneal injection of 20
mg OVA plus 2.25 mg alum on day 1. For DC-derived immunization,
OVA-pulsed DCs (1 3 106 cells) were transferred with 5 3 106 cells
of whole or GFP-deleted CD4 T cells injected into the footpad of
the B cell-transferred RAG-deficient mice. Mice were boosted with
OVA in PBS 4 times every 5 days. Serum levels of total IgG1,
IgG2a, and IgE were measured by ELISA as previously described
(Tanigaki et al., 2004). OVA-specific IgE was detected by modified
IgE capture ELISA system with biotin-conjugated OVA.
OVA-Induced Infiltration of CD4 T Cells
Mice were sensitized by intraperitoneal injection of 20 mg OVA plus
2.25 mg alum on days 1 and 14. On days 26–28, mice received aero-
sol challenge containing either saline or 1% OVA for 20 min per day.
On day 30, cells were collected from BAL fluid and analyzed for
GFP+CD4 cells.
Supplemental Data
One Supplemental Figure can be found with this article online at
http://www.immunity.com/cgi/content/full/24/6/689/DC1/.
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